logo

ACB

Aurora Cannabis·NASDAQ
--
--(--)
--
--(--)
6.65 / 10
Outperform

ACB's fundamental profile is encouraging: Days Sales Outstanding at 46.08 (Group 1) indicates moderate receivable collection speed; a 27.32% YoY revenue growth places it in performance Group 2; and an Interest Coverage Ratio of 42.48 (Group 1) suggests solid interest payment capacity. Metrics like Revenue-MV (0.58), Profit-MV (0.44), and Asset-MV (0.42) fall into favorable groups, while Cash-MV (-1.19) and PB-ROE (-0.70) show room for improvement. Overall, the fundamentals score 6.7/10, earning an 'Outperform' rating.

Fundamental(6.65)SentimentTechnical

Analysis Checks(10/10)

Revenue-MV
Value0.58
Score3/3
Weight15.59%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value27.32
Score2/3
Weight1.33%
1M Return1.11%
Days sales outstanding
Value46.08
Score2/3
Weight1.35%
1M Return1.10%
Profit-MV
Value0.44
Score2/3
Weight12.43%
1M Return8.45%
Net income-Revenue
Value0.15
Score2/3
Weight12.44%
1M Return8.45%
PB-ROE
Value-0.70
Score3/3
Weight16.85%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.24%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value27.32
Score2/3
Weight0.51%
1M Return0.43%
Asset-MV
Value0.42
Score3/3
Weight23.05%
1M Return13.15%
Cash-MV
Value-1.19
Score3/3
Weight17.69%
1M Return9.67%
Is ACB fundamentally strong?
  • ACB scores 6.65/10 on fundamentals and holds a Discounted valuation at present. Backed by its -12.72% ROE, -24.69% net margin, -2.99 P/E ratio, 0.48 P/B ratio, and -5728.33% earnings growth, these metrics solidify its Outperform investment rating.